| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 3.22e-08 | 40 | 17 | 4 | GO:0140662 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 3.77e-07 | 73 | 17 | 4 | GO:0044183 | |
| GeneOntologyMolecularFunction | CTP binding | 6.82e-07 | 2 | 17 | 2 | GO:0002135 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor binding | 2.05e-06 | 3 | 17 | 2 | GO:0017098 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 3.38e-06 | 126 | 17 | 4 | GO:0051082 | |
| GeneOntologyMolecularFunction | UTP binding | 4.09e-06 | 4 | 17 | 2 | GO:0002134 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 4.60e-06 | 39 | 17 | 3 | GO:0097718 | |
| GeneOntologyMolecularFunction | pyrimidine ribonucleotide binding | 6.81e-06 | 5 | 17 | 2 | GO:0032557 | |
| GeneOntologyMolecularFunction | dATP binding | 6.81e-06 | 5 | 17 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 1.02e-05 | 6 | 17 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 1.43e-05 | 7 | 17 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | TPR domain binding | 1.90e-05 | 8 | 17 | 2 | GO:0030911 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 2.45e-05 | 9 | 17 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.55e-05 | 441 | 17 | 5 | GO:0016887 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 3.06e-05 | 10 | 17 | 2 | GO:0030235 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide binding | 3.74e-05 | 11 | 17 | 2 | GO:0019103 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.23e-04 | 614 | 17 | 5 | GO:0140657 | |
| GeneOntologyMolecularFunction | DNA polymerase binding | 1.71e-04 | 23 | 17 | 2 | GO:0070182 | |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 2.36e-04 | 27 | 17 | 2 | GO:0023026 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 3.64e-04 | 775 | 17 | 5 | GO:0017111 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 3.91e-04 | 172 | 17 | 3 | GO:0044325 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 5.25e-04 | 839 | 17 | 5 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 5.28e-04 | 840 | 17 | 5 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 5.28e-04 | 840 | 17 | 5 | GO:0016818 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 5.49e-04 | 41 | 17 | 2 | GO:0023023 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 6.36e-04 | 875 | 17 | 5 | GO:0019904 | |
| GeneOntologyMolecularFunction | tau protein binding | 6.91e-04 | 46 | 17 | 2 | GO:0048156 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 2.72e-03 | 337 | 17 | 3 | GO:0031625 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 2.79e-03 | 93 | 17 | 2 | GO:0097110 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 3.22e-03 | 358 | 17 | 3 | GO:0044389 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 6.81e-03 | 147 | 17 | 2 | GO:0042826 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 1.22e-02 | 1099 | 17 | 4 | GO:0008092 | |
| GeneOntologyBiologicalProcess | telomerase holoenzyme complex assembly | 9.57e-06 | 6 | 17 | 2 | GO:1905323 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 3.81e-05 | 81 | 17 | 3 | GO:0034605 | |
| GeneOntologyBiologicalProcess | protein folding | 4.16e-05 | 246 | 17 | 4 | GO:0006457 | |
| GeneOntologyBiologicalProcess | positive regulation of cell size | 1.08e-04 | 19 | 17 | 2 | GO:0045793 | |
| GeneOntologyBiologicalProcess | response to heat | 1.26e-04 | 121 | 17 | 3 | GO:0009408 | |
| GeneOntologyBiologicalProcess | chaperone-mediated protein complex assembly | 1.90e-04 | 25 | 17 | 2 | GO:0051131 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 3.32e-04 | 168 | 17 | 3 | GO:0000723 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion | 3.96e-04 | 36 | 17 | 2 | GO:0007064 | |
| GeneOntologyBiologicalProcess | telomere organization | 5.44e-04 | 199 | 17 | 3 | GO:0032200 | |
| GeneOntologyBiologicalProcess | response to temperature stimulus | 6.19e-04 | 208 | 17 | 3 | GO:0009266 | |
| GeneOntologyCellularComponent | dendritic growth cone | 3.61e-05 | 12 | 16 | 2 | GO:0044294 | |
| GeneOntologyCellularComponent | dendrite terminus | 1.04e-04 | 20 | 16 | 2 | GO:0044292 | |
| GeneOntologyCellularComponent | sperm plasma membrane | 1.26e-04 | 22 | 16 | 2 | GO:0097524 | |
| GeneOntologyCellularComponent | mitotic spindle pole | 4.87e-04 | 43 | 16 | 2 | GO:0097431 | |
| GeneOntologyCellularComponent | axonal growth cone | 5.33e-04 | 45 | 16 | 2 | GO:0044295 | |
| GeneOntologyCellularComponent | brush border membrane | 1.80e-03 | 83 | 16 | 2 | GO:0031526 | |
| GeneOntologyCellularComponent | inclusion body | 2.12e-03 | 90 | 16 | 2 | GO:0016234 | |
| GeneOntologyCellularComponent | pigment granule | 3.31e-03 | 113 | 16 | 2 | GO:0048770 | |
| GeneOntologyCellularComponent | melanosome | 3.31e-03 | 113 | 16 | 2 | GO:0042470 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 3.97e-03 | 124 | 16 | 2 | GO:1904813 | |
| GeneOntologyCellularComponent | cell projection membrane | 3.99e-03 | 431 | 16 | 3 | GO:0031253 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 4.68e-03 | 934 | 16 | 4 | GO:0048471 | |
| GeneOntologyCellularComponent | apical plasma membrane | 5.61e-03 | 487 | 16 | 3 | GO:0016324 | |
| GeneOntologyCellularComponent | brush border | 5.90e-03 | 152 | 16 | 2 | GO:0005903 | |
| GeneOntologyCellularComponent | secretory granule | 6.27e-03 | 1014 | 16 | 4 | GO:0030141 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 8.62e-03 | 185 | 16 | 2 | GO:0101002 | |
| GeneOntologyCellularComponent | apical part of cell | 9.61e-03 | 592 | 16 | 3 | GO:0045177 | |
| GeneOntologyCellularComponent | mitotic spindle | 1.01e-02 | 201 | 16 | 2 | GO:0072686 | |
| GeneOntologyCellularComponent | spindle pole | 1.05e-02 | 205 | 16 | 2 | GO:0000922 | |
| HumanPheno | Hooded eyelid | 1.15e-05 | 6 | 5 | 2 | HP:0030820 | |
| Domain | Heat_shock_protein_90_CS | 1.81e-06 | 3 | 15 | 2 | IPR019805 | |
| Domain | DUF3496 | 1.81e-06 | 3 | 15 | 2 | IPR021885 | |
| Domain | DUF3496 | 1.81e-06 | 3 | 15 | 2 | PF12001 | |
| Domain | HSP90 | 3.61e-06 | 4 | 15 | 2 | PF00183 | |
| Domain | Hsp90_N | 3.61e-06 | 4 | 15 | 2 | IPR020575 | |
| Domain | HSP90 | 3.61e-06 | 4 | 15 | 2 | PS00298 | |
| Domain | Hsp90_fam | 3.61e-06 | 4 | 15 | 2 | IPR001404 | |
| Domain | CNH | 5.45e-05 | 14 | 15 | 2 | SM00036 | |
| Domain | CNH_dom | 6.28e-05 | 15 | 15 | 2 | IPR001180 | |
| Domain | CNH | 6.28e-05 | 15 | 15 | 2 | PS50219 | |
| Domain | CNH | 6.28e-05 | 15 | 15 | 2 | PF00780 | |
| Domain | HATPase_c | 9.14e-05 | 18 | 15 | 2 | SM00387 | |
| Domain | HATPase_c | 1.02e-04 | 19 | 15 | 2 | PF02518 | |
| Domain | - | 1.13e-04 | 20 | 15 | 2 | 3.30.565.10 | |
| Domain | HATPase_C | 1.25e-04 | 21 | 15 | 2 | IPR003594 | |
| Domain | Ribosomal_S5_D2-typ_fold | 3.33e-04 | 34 | 15 | 2 | IPR020568 | |
| Domain | Ank_2 | 6.18e-04 | 215 | 15 | 3 | PF12796 | |
| Domain | Ank | 7.33e-04 | 228 | 15 | 3 | PF00023 | |
| Domain | - | 9.35e-04 | 248 | 15 | 3 | 1.25.40.20 | |
| Domain | ANK | 9.68e-04 | 251 | 15 | 3 | SM00248 | |
| Domain | ANK_REPEAT | 9.91e-04 | 253 | 15 | 3 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.00e-03 | 254 | 15 | 3 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.00e-03 | 254 | 15 | 3 | PS50297 | |
| Domain | Ankyrin_rpt | 1.10e-03 | 262 | 15 | 3 | IPR002110 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 9.59e-06 | 51 | 12 | 3 | MM14967 | |
| Pathway | REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN | 9.95e-06 | 6 | 12 | 2 | M27430 | |
| Pathway | REACTOME_HSF1_ACTIVATION | 1.85e-05 | 8 | 12 | 2 | MM14950 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.91e-05 | 64 | 12 | 3 | M7923 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 5.15e-05 | 13 | 12 | 2 | MM14952 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 6.01e-05 | 14 | 12 | 2 | MM15029 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION | 7.92e-05 | 16 | 12 | 2 | M48235 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 7.92e-05 | 16 | 12 | 2 | M16498 | |
| Pathway | REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY | 1.52e-04 | 22 | 12 | 2 | M27937 | |
| Pathway | REACTOME_RHOBTB2_GTPASE_CYCLE | 1.66e-04 | 23 | 12 | 2 | M41723 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.66e-04 | 23 | 12 | 2 | MM14953 | |
| Pathway | REACTOME_RHOBTB2_GTPASE_CYCLE | 1.97e-04 | 25 | 12 | 2 | MM15606 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 2.10e-04 | 143 | 12 | 3 | M27107 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 2.37e-04 | 149 | 12 | 3 | M27888 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 2.48e-04 | 28 | 12 | 2 | M27254 | |
| Pathway | REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS | 2.66e-04 | 29 | 12 | 2 | M27431 | |
| Pathway | REACTOME_HSF1_ACTIVATION | 3.05e-04 | 31 | 12 | 2 | M27252 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 3.46e-04 | 33 | 12 | 2 | MM14666 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 3.76e-04 | 439 | 12 | 4 | MM15595 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 3.89e-04 | 35 | 12 | 2 | M41738 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 4.14e-04 | 450 | 12 | 4 | M27078 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 4.35e-04 | 37 | 12 | 2 | MM15683 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 4.59e-04 | 38 | 12 | 2 | M27255 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 6.73e-04 | 46 | 12 | 2 | M8626 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 7.43e-04 | 220 | 12 | 3 | M27794 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 8.60e-04 | 52 | 12 | 2 | MM14949 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.03e-03 | 57 | 12 | 2 | M27251 | |
| Pathway | WP_15Q11Q13_COPY_NUMBER_VARIATION | 1.11e-03 | 59 | 12 | 2 | M48104 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.22e-03 | 261 | 12 | 3 | MM15676 | |
| Pathway | KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.22e-03 | 62 | 12 | 2 | M15569 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.26e-03 | 63 | 12 | 2 | MM15613 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 1.51e-03 | 69 | 12 | 2 | M237 | |
| Pathway | REACTOME_BACTERIAL_INFECTION_PATHWAYS | 1.60e-03 | 71 | 12 | 2 | M48033 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 1.64e-03 | 649 | 12 | 4 | MM15690 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.69e-03 | 73 | 12 | 2 | MM15491 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.73e-03 | 74 | 12 | 2 | M160 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.75e-03 | 296 | 12 | 3 | M27869 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.97e-03 | 79 | 12 | 2 | M27743 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 2.12e-03 | 82 | 12 | 2 | M1002 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 2.28e-03 | 85 | 12 | 2 | M3578 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 2.40e-03 | 720 | 12 | 4 | M41838 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 2.44e-03 | 88 | 12 | 2 | M16004 | |
| Pathway | KEGG_PROSTATE_CANCER | 2.50e-03 | 89 | 12 | 2 | M13191 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.66e-03 | 92 | 12 | 2 | MM14951 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 3.20e-03 | 101 | 12 | 2 | M27253 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 3.52e-03 | 106 | 12 | 2 | M27077 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 3.99e-03 | 113 | 12 | 2 | M16817 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 4.06e-03 | 114 | 12 | 2 | MM14814 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 4.49e-03 | 120 | 12 | 2 | M48233 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 4.93e-03 | 126 | 12 | 2 | M45009 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 5.48e-03 | 133 | 12 | 2 | MM15529 | |
| Pathway | WP_NRF2_PATHWAY | 6.14e-03 | 141 | 12 | 2 | M39454 | |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 7.28e-03 | 154 | 12 | 2 | M39007 | |
| Pathway | REACTOME_AUTOPHAGY | 7.65e-03 | 158 | 12 | 2 | M27935 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 7.77e-03 | 502 | 12 | 3 | MM14537 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 8.32e-03 | 165 | 12 | 2 | MM15026 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 1.03e-02 | 184 | 12 | 2 | MM15145 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | 1.05e-02 | 561 | 12 | 3 | M5336 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.10e-02 | 191 | 12 | 2 | MM15586 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.13e-02 | 575 | 12 | 3 | M29853 | |
| Pubmed | The HSP90 family of genes in the human genome: insights into their divergence and evolution. | 7.08e-11 | 16 | 17 | 4 | 16269234 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 7.79e-08 | 847 | 17 | 7 | 35235311 | |
| Pubmed | 1.43e-07 | 538 | 17 | 6 | 28524877 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 10376793 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 33080545 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 37011862 | ||
| Pubmed | Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target. | 2.25e-07 | 2 | 17 | 2 | 33179566 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 36270993 | ||
| Pubmed | Hsp90 regulation of fibroblast activation in pulmonary fibrosis. | 2.25e-07 | 2 | 17 | 2 | 28239659 | |
| Pubmed | Regulation of embryonic stem cell pluripotency by heat shock protein 90. | 2.25e-07 | 2 | 17 | 2 | 22696450 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 37028636 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 37406487 | ||
| Pubmed | Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumors. | 2.25e-07 | 2 | 17 | 2 | 22194440 | |
| Pubmed | Circadian expression of 86- and 84-kDa heat shock proteins in the mouse suprachiasmatic nucleus. | 2.25e-07 | 2 | 17 | 2 | 18480550 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 22895790 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 22841823 | ||
| Pubmed | Hsp90 is cleaved by reactive oxygen species at a highly conserved N-terminal amino acid motif. | 2.25e-07 | 2 | 17 | 2 | 22848402 | |
| Pubmed | Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue. | 2.25e-07 | 2 | 17 | 2 | 19576239 | |
| Pubmed | A mouse tumor-specific transplantation antigen is a heat shock-related protein. | 2.25e-07 | 2 | 17 | 2 | 3458168 | |
| Pubmed | Mechanism of dimer formation of the 90-kDa heat-shock protein. | 2.25e-07 | 2 | 17 | 2 | 7588731 | |
| Pubmed | Substitution of only two residues of human Hsp90alpha causes impeded dimerization of Hsp90beta. | 2.25e-07 | 2 | 17 | 2 | 18347946 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 2925609 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 19047110 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 2469626 | ||
| Pubmed | Conserved conformational changes in the ATPase cycle of human Hsp90. | 2.25e-07 | 2 | 17 | 2 | 18400751 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 22019372 | ||
| Pubmed | Heat shock protein HSP86 expression during mouse embryo development, especially in the germ-line. | 2.25e-07 | 2 | 17 | 2 | 12136260 | |
| Pubmed | Conformational diversity in the TPR domain-mediated interaction of protein phosphatase 5 with Hsp90. | 6.74e-07 | 3 | 17 | 2 | 16531226 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 33145341 | ||
| Pubmed | Molecular recognition via coupled folding and binding in a TPR domain. | 6.74e-07 | 3 | 17 | 2 | 15713458 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 19996089 | ||
| Pubmed | HSP-enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells. | 6.74e-07 | 3 | 17 | 2 | 29768689 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 2492519 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 1406681 | ||
| Pubmed | Mammalian CHORD-containing protein 1 is a novel heat shock protein 90-interacting protein. | 6.74e-07 | 3 | 17 | 2 | 15642353 | |
| Pubmed | Mutations that increase both Hsp90 ATPase activity in vitro and Hsp90 drug resistance in vivo. | 6.74e-07 | 3 | 17 | 2 | 20226818 | |
| Pubmed | Hsp90 activity is necessary to acquire a proper neuronal polarization. | 6.74e-07 | 3 | 17 | 2 | 24286867 | |
| Pubmed | Hsp90 regulates the activity of wild type p53 under physiological and elevated temperatures. | 6.74e-07 | 3 | 17 | 2 | 15358771 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 24511009 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 10995457 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 18550790 | ||
| Pubmed | Chaperone ligand-discrimination by the TPR-domain protein Tah1. | 6.74e-07 | 3 | 17 | 2 | 18412542 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 16698020 | ||
| Pubmed | N-terminal domain of human Hsp90 triggers binding to the cochaperone p23. | 6.74e-07 | 3 | 17 | 2 | 21183720 | |
| Pubmed | Synergistic role of HSP90α and HSP90β to promote myofibroblast persistence in lung fibrosis. | 6.74e-07 | 3 | 17 | 2 | 29386344 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 22843495 | ||
| Pubmed | HSP90 affects the stability of BMAL1 and circadian gene expression. | 6.74e-07 | 3 | 17 | 2 | 24682203 | |
| Pubmed | HSP90 regulates cell survival via inositol hexakisphosphate kinase-2. | 6.74e-07 | 3 | 17 | 2 | 18195352 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 19158073 | ||
| Pubmed | Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells. | 6.74e-07 | 3 | 17 | 2 | 22849407 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 35043518 | ||
| Pubmed | Stabilization of Notch1 by the Hsp90 Chaperone Is Crucial for T-Cell Leukemogenesis. | 1.35e-06 | 4 | 17 | 2 | 28143869 | |
| Pubmed | Identification of HSP90 as a new GABARAPL1 (GEC1)-interacting protein. | 1.35e-06 | 4 | 17 | 2 | 22120110 | |
| Pubmed | Functional requirement of p23 and Hsp90 in telomerase complexes. | 1.35e-06 | 4 | 17 | 2 | 10197982 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 34196494 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 31449053 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 15791211 | ||
| Pubmed | A heat-shock protein axis regulates VEGFR2 proteolysis, blood vessel development and repair. | 1.35e-06 | 4 | 17 | 2 | 23139789 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 16394098 | ||
| Pubmed | REV-ERBα influences the stability and nuclear localization of the glucocorticoid receptor. | 1.35e-06 | 4 | 17 | 2 | 27686098 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 19751963 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 11036079 | ||
| Pubmed | Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis. | 1.35e-06 | 4 | 17 | 2 | 15782121 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 27418101 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 12482853 | ||
| Pubmed | Hsp90 interactions and acylation target the G protein Galpha 12 but not Galpha 13 to lipid rafts. | 1.35e-06 | 4 | 17 | 2 | 12117999 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 22367781 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 32600329 | ||
| Pubmed | Involvement of heat-shock protein 90 in the interleukin-6-mediated signaling pathway through STAT3. | 1.35e-06 | 4 | 17 | 2 | 12559950 | |
| Pubmed | Defining the Na+/H+ exchanger NHE1 interactome in triple-negative breast cancer cells. | 1.45e-06 | 46 | 17 | 3 | 27751915 | |
| Pubmed | 1.99e-06 | 51 | 17 | 3 | 36896912 | ||
| Pubmed | 2.24e-06 | 197 | 17 | 4 | 31620119 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 18474241 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 16501598 | ||
| Pubmed | MafG controls the hypoxic response of cells by accumulating HIF-1alpha in the nuclei. | 2.25e-06 | 5 | 17 | 2 | 18538669 | |
| Pubmed | Chaperoning checkpoint kinase 1 (Chk1), an Hsp90 client, with purified chaperones. | 2.25e-06 | 5 | 17 | 2 | 16330544 | |
| Pubmed | HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. | 2.25e-06 | 5 | 17 | 2 | 15916966 | |
| Pubmed | Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy. | 2.25e-06 | 5 | 17 | 2 | 21855797 | |
| Pubmed | Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation. | 2.25e-06 | 5 | 17 | 2 | 19586661 | |
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 16314389 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 19805107 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 9083006 | ||
| Pubmed | Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling. | 2.25e-06 | 5 | 17 | 2 | 15001580 | |
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 19996313 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 25486457 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 20930503 | ||
| Pubmed | GCUNC45 is the first Hsp90 co-chaperone to show alpha/beta isoform specificity. | 2.25e-06 | 5 | 17 | 2 | 18285346 | |
| Pubmed | 3.14e-06 | 497 | 17 | 5 | 23414517 | ||
| Pubmed | Defective Tibetan PHD2 binding to p23 links high altitude adaption to altered oxygen sensing. | 3.37e-06 | 6 | 17 | 2 | 24711448 | |
| Pubmed | Mixed Hsp90-cochaperone complexes are important for the progression of the reaction cycle. | 3.37e-06 | 6 | 17 | 2 | 21170051 | |
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 11707401 | ||
| Pubmed | URI is required to maintain intestinal architecture during ionizing radiation. | 3.37e-06 | 6 | 17 | 2 | 31147493 | |
| Pubmed | Structural basis for phosphorylation-dependent recruitment of Tel2 to Hsp90 by Pih1. | 3.37e-06 | 6 | 17 | 2 | 24794838 | |
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 9261129 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 22718348 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 26414348 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 32206096 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 16083881 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 18003639 | ||
| Pubmed | Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex. | 3.37e-06 | 6 | 17 | 2 | 30382094 | |
| Interaction | CDKL4 interactions | 2.47e-10 | 13 | 17 | 4 | int:CDKL4 | |
| Interaction | UNC45B interactions | 2.51e-09 | 22 | 17 | 4 | int:UNC45B | |
| Interaction | CCDC117 interactions | 5.12e-09 | 26 | 17 | 4 | int:CCDC117 | |
| Interaction | STK35 interactions | 9.37e-09 | 30 | 17 | 4 | int:STK35 | |
| Interaction | RPS6KA4 interactions | 1.60e-08 | 100 | 17 | 5 | int:RPS6KA4 | |
| Interaction | SRMS interactions | 3.11e-08 | 40 | 17 | 4 | int:SRMS | |
| Interaction | AURKC interactions | 4.19e-08 | 43 | 17 | 4 | int:AURKC | |
| Interaction | SGK2 interactions | 4.19e-08 | 43 | 17 | 4 | int:SGK2 | |
| Interaction | TSSK6 interactions | 6.04e-08 | 47 | 17 | 4 | int:TSSK6 | |
| Interaction | MAP2K2 interactions | 7.11e-08 | 278 | 17 | 6 | int:MAP2K2 | |
| Interaction | MAP3K6 interactions | 8.45e-08 | 51 | 17 | 4 | int:MAP3K6 | |
| Interaction | CDK4 interactions | 9.51e-08 | 292 | 17 | 6 | int:CDK4 | |
| Interaction | GBP2 interactions | 1.07e-07 | 54 | 17 | 4 | int:GBP2 | |
| Interaction | AMHR2 interactions | 1.24e-07 | 56 | 17 | 4 | int:AMHR2 | |
| Interaction | ITK interactions | 1.88e-07 | 62 | 17 | 4 | int:ITK | |
| Interaction | SMYD3 interactions | 3.25e-07 | 71 | 17 | 4 | int:SMYD3 | |
| Interaction | PDIK1L interactions | 6.57e-07 | 21 | 17 | 3 | int:PDIK1L | |
| Interaction | AKT3 interactions | 6.73e-07 | 85 | 17 | 4 | int:AKT3 | |
| Interaction | STK32C interactions | 7.39e-07 | 87 | 17 | 4 | int:STK32C | |
| Interaction | MYLK4 interactions | 8.47e-07 | 90 | 17 | 4 | int:MYLK4 | |
| Interaction | GUCY2D interactions | 8.74e-07 | 23 | 17 | 3 | int:GUCY2D | |
| Interaction | INSRR interactions | 9.66e-07 | 93 | 17 | 4 | int:INSRR | |
| Interaction | PTGES3 interactions | 1.02e-06 | 437 | 17 | 6 | int:PTGES3 | |
| Interaction | GRK7 interactions | 1.13e-06 | 25 | 17 | 3 | int:GRK7 | |
| Interaction | ANKK1 interactions | 2.21e-06 | 31 | 17 | 3 | int:ANKK1 | |
| Interaction | PPP5C interactions | 2.34e-06 | 272 | 17 | 5 | int:PPP5C | |
| Interaction | CDK15 interactions | 2.42e-06 | 117 | 17 | 4 | int:CDK15 | |
| Interaction | STK33 interactions | 4.13e-06 | 38 | 17 | 3 | int:STK33 | |
| Interaction | BTK interactions | 5.69e-06 | 145 | 17 | 4 | int:BTK | |
| Interaction | HSP90AB1 interactions | 6.95e-06 | 960 | 17 | 7 | int:HSP90AB1 | |
| Interaction | AGO3 interactions | 7.04e-06 | 153 | 17 | 4 | int:AGO3 | |
| Interaction | CDK13 interactions | 7.04e-06 | 153 | 17 | 4 | int:CDK13 | |
| Interaction | STIP1 interactions | 9.46e-06 | 1006 | 17 | 7 | int:STIP1 | |
| Interaction | PINK1 interactions | 1.29e-05 | 679 | 17 | 6 | int:PINK1 | |
| Interaction | CDK11A interactions | 1.34e-05 | 180 | 17 | 4 | int:CDK11A | |
| Interaction | SBK2 interactions | 1.40e-05 | 7 | 17 | 2 | int:SBK2 | |
| Interaction | MAP3K11 interactions | 1.66e-05 | 60 | 17 | 3 | int:MAP3K11 | |
| Interaction | LYN interactions | 1.80e-05 | 720 | 17 | 6 | int:LYN | |
| Interaction | SLC17A1 interactions | 1.87e-05 | 8 | 17 | 2 | int:SLC17A1 | |
| Interaction | NLRC3 interactions | 1.87e-05 | 8 | 17 | 2 | int:NLRC3 | |
| Interaction | PSKH2 interactions | 2.31e-05 | 67 | 17 | 3 | int:PSKH2 | |
| Interaction | ZNF541 interactions | 2.40e-05 | 9 | 17 | 2 | int:ZNF541 | |
| Interaction | LCK interactions | 3.08e-05 | 463 | 17 | 5 | int:LCK | |
| Interaction | NUMA1 interactions | 3.28e-05 | 469 | 17 | 5 | int:NUMA1 | |
| Interaction | ANKRD55 interactions | 3.38e-05 | 228 | 17 | 4 | int:ANKRD55 | |
| Interaction | HLA-DRB4 interactions | 4.40e-05 | 12 | 17 | 2 | int:HLA-DRB4 | |
| Interaction | UNC13C interactions | 4.40e-05 | 12 | 17 | 2 | int:UNC13C | |
| Interaction | MYG1 interactions | 4.55e-05 | 84 | 17 | 3 | int:MYG1 | |
| Interaction | FKBP6 interactions | 4.89e-05 | 86 | 17 | 3 | int:FKBP6 | |
| Interaction | BMX interactions | 5.60e-05 | 90 | 17 | 3 | int:BMX | |
| Interaction | FGR interactions | 6.17e-05 | 93 | 17 | 3 | int:FGR | |
| Interaction | HSP90AA5P interactions | 6.17e-05 | 93 | 17 | 3 | int:HSP90AA5P | |
| Interaction | TRAF3IP1 interactions | 6.79e-05 | 96 | 17 | 3 | int:TRAF3IP1 | |
| Interaction | LY6E interactions | 6.99e-05 | 15 | 17 | 2 | int:LY6E | |
| Interaction | TESK2 interactions | 7.00e-05 | 97 | 17 | 3 | int:TESK2 | |
| Interaction | HSP90AB3P interactions | 7.22e-05 | 98 | 17 | 3 | int:HSP90AB3P | |
| Interaction | MYLK2 interactions | 7.89e-05 | 101 | 17 | 3 | int:MYLK2 | |
| Interaction | FKBP4 interactions | 8.06e-05 | 285 | 17 | 4 | int:FKBP4 | |
| Interaction | LRRK1 interactions | 8.13e-05 | 102 | 17 | 3 | int:LRRK1 | |
| Interaction | PTK6 interactions | 8.61e-05 | 104 | 17 | 3 | int:PTK6 | |
| Interaction | SCG2 interactions | 9.04e-05 | 17 | 17 | 2 | int:SCG2 | |
| Interaction | IKBKE interactions | 9.12e-05 | 106 | 17 | 3 | int:IKBKE | |
| Interaction | FBXL4 interactions | 9.12e-05 | 106 | 17 | 3 | int:FBXL4 | |
| Interaction | CEBPB interactions | 9.75e-05 | 1443 | 17 | 7 | int:CEBPB | |
| Interaction | NANS interactions | 9.90e-05 | 109 | 17 | 3 | int:NANS | |
| Interaction | STK32A interactions | 1.02e-04 | 18 | 17 | 2 | int:STK32A | |
| Interaction | CDK3 interactions | 1.13e-04 | 114 | 17 | 3 | int:CDK3 | |
| Interaction | SLC34A1 interactions | 1.14e-04 | 19 | 17 | 2 | int:SLC34A1 | |
| Interaction | TNNI3K interactions | 1.14e-04 | 19 | 17 | 2 | int:TNNI3K | |
| Interaction | AGO4 interactions | 1.25e-04 | 118 | 17 | 3 | int:AGO4 | |
| Interaction | MAP2K5 interactions | 1.32e-04 | 120 | 17 | 3 | int:MAP2K5 | |
| Interaction | STK11 interactions | 1.35e-04 | 326 | 17 | 4 | int:STK11 | |
| Interaction | IP6K2 interactions | 1.39e-04 | 21 | 17 | 2 | int:IP6K2 | |
| Interaction | SYNDIG1 interactions | 1.39e-04 | 21 | 17 | 2 | int:SYNDIG1 | |
| Interaction | CDC37 interactions | 1.49e-04 | 645 | 17 | 5 | int:CDC37 | |
| Interaction | FAF1 interactions | 1.49e-04 | 334 | 17 | 4 | int:FAF1 | |
| Interaction | DTX4 interactions | 1.53e-04 | 22 | 17 | 2 | int:DTX4 | |
| Interaction | ZNF215 interactions | 1.53e-04 | 22 | 17 | 2 | int:ZNF215 | |
| Interaction | NUDC interactions | 1.54e-04 | 337 | 17 | 4 | int:NUDC | |
| Interaction | HSP90B1 interactions | 1.54e-04 | 650 | 17 | 5 | int:HSP90B1 | |
| Interaction | CHORDC1 interactions | 1.67e-04 | 130 | 17 | 3 | int:CHORDC1 | |
| Interaction | MAP4K1 interactions | 1.67e-04 | 130 | 17 | 3 | int:MAP4K1 | |
| Interaction | MAP3K15 interactions | 1.68e-04 | 23 | 17 | 2 | int:MAP3K15 | |
| Interaction | GSDMD interactions | 1.68e-04 | 23 | 17 | 2 | int:GSDMD | |
| Interaction | CDK18 interactions | 1.71e-04 | 131 | 17 | 3 | int:CDK18 | |
| Interaction | FTL interactions | 1.74e-04 | 348 | 17 | 4 | int:FTL | |
| Interaction | MTOR interactions | 1.76e-04 | 349 | 17 | 4 | int:MTOR | |
| Interaction | PCBP1 interactions | 1.79e-04 | 671 | 17 | 5 | int:PCBP1 | |
| Interaction | SPHKAP interactions | 1.83e-04 | 24 | 17 | 2 | int:SPHKAP | |
| Interaction | TTC9C interactions | 1.91e-04 | 136 | 17 | 3 | int:TTC9C | |
| Interaction | LURAP1 interactions | 1.95e-04 | 137 | 17 | 3 | int:LURAP1 | |
| Interaction | CDK9 interactions | 1.97e-04 | 685 | 17 | 5 | int:CDK9 | |
| Interaction | NEK11 interactions | 1.99e-04 | 25 | 17 | 2 | int:NEK11 | |
| Interaction | ITGB1BP2 interactions | 1.99e-04 | 25 | 17 | 2 | int:ITGB1BP2 | |
| Interaction | CDKL1 interactions | 1.99e-04 | 25 | 17 | 2 | int:CDKL1 | |
| Interaction | MOB3C interactions | 2.07e-04 | 364 | 17 | 4 | int:MOB3C | |
| Interaction | YWHAQ interactions | 2.10e-04 | 1118 | 17 | 6 | int:YWHAQ | |
| Interaction | DDX59 interactions | 2.15e-04 | 26 | 17 | 2 | int:DDX59 | |
| Interaction | METTL22 interactions | 2.15e-04 | 26 | 17 | 2 | int:METTL22 | |
| Interaction | TSSK2 interactions | 2.15e-04 | 26 | 17 | 2 | int:TSSK2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p13 | 1.87e-03 | 174 | 17 | 2 | chr9p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 1.46e-02 | 503 | 17 | 2 | chr6p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q32 | 1.83e-02 | 566 | 17 | 2 | chr14q32 | |
| GeneFamily | Heat shock 90kDa proteins | 4.77e-06 | 5 | 13 | 2 | 586 | |
| GeneFamily | Ankyrin repeat domain containing | 6.13e-04 | 242 | 13 | 3 | 403 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 3.36e-05 | 656 | 16 | 5 | M18979 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | 7.34e-05 | 1290 | 16 | 6 | M80 | |
| Coexpression | WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP | 7.78e-05 | 392 | 16 | 4 | M2131 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 8.74e-05 | 404 | 16 | 4 | M19488 | |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP | 1.81e-04 | 185 | 16 | 3 | M377 | |
| Coexpression | GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN | 1.96e-04 | 190 | 16 | 3 | M384 | |
| Coexpression | GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP | 2.24e-04 | 199 | 16 | 3 | M5978 | |
| Coexpression | GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_DN | 2.28e-04 | 200 | 16 | 3 | M9050 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN | 2.28e-04 | 200 | 16 | 3 | M5081 | |
| Coexpression | GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN | 2.28e-04 | 200 | 16 | 3 | M3202 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN | 2.28e-04 | 200 | 16 | 3 | M8208 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_FIBROBLAST_OF_LUNG_AGEING | 3.18e-04 | 224 | 16 | 3 | MM3767 | |
| Coexpression | SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP | 3.41e-04 | 45 | 16 | 2 | M104 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ADVENTITIAL_CELL_AGEING | 3.61e-04 | 234 | 16 | 3 | MM3761 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | 3.99e-06 | 1468 | 16 | 8 | facebase_RNAseq_e10.5_MandArch_2500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 1.64e-05 | 1241 | 16 | 7 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 2.45e-05 | 498 | 16 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 5.38e-05 | 989 | 16 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 2.03e-04 | 1257 | 16 | 6 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.57e-04 | 169 | 16 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.74e-04 | 192 | 16 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | 3.86e-04 | 1414 | 16 | 6 | facebase_RNAseq_e10.5_Emin_MedNas_2500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 4.58e-04 | 1459 | 16 | 6 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 5.99e-04 | 983 | 16 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | 6.22e-04 | 991 | 16 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.59e-07 | 187 | 17 | 4 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 8.12e-07 | 197 | 17 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 8.45e-07 | 199 | 17 | 4 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 8.45e-07 | 199 | 17 | 4 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.86e-05 | 138 | 17 | 3 | 93497c0a5d5e54006653b2dedc7a7041e1a613e6 | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.23e-05 | 166 | 17 | 3 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-05 | 169 | 17 | 3 | d4a0bd792bddfa34332d7dc432ce253f50d98c6f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-05 | 177 | 17 | 3 | ea2c2d2d7ffd34780882299229ff8614fdd7c79c | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-05 | 177 | 17 | 3 | 63b5ebbe505f22091bc7b0db818e01fae5d92bb7 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 3.91e-05 | 177 | 17 | 3 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 178 | 17 | 3 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 3.97e-05 | 178 | 17 | 3 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.25e-05 | 182 | 17 | 3 | b86690c109cdc16844a6cd2216c1bf2bf28efd45 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 183 | 17 | 3 | 7534587fa35837c0aaca93c542f2eee493eba637 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.53e-05 | 186 | 17 | 3 | 855c2e5a8a6cf94c7de31982e0e2416f924439d3 | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 4.60e-05 | 187 | 17 | 3 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 4.68e-05 | 188 | 17 | 3 | a20521198c6db17589535fb439533329582c9dd2 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17|Lung / Manually curated celltypes from each tissue | 4.75e-05 | 189 | 17 | 3 | f43960506ed3e699e910ec7711c1113e2e9b80d1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.83e-05 | 190 | 17 | 3 | 4d401b73c0e7eb38e95d0851a128bf12bb0d3a9f | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 4.90e-05 | 191 | 17 | 3 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | 10x3'2.3|World / cell types per 3 fetal stages;per 3',per 5' | 5.13e-05 | 194 | 17 | 3 | fc7ed8350ffe1475b8934dfbb107b51991876b0b | |
| ToppCell | HSPCs-Mk_prog.|World / Lineage and Cell class | 5.13e-05 | 194 | 17 | 3 | 5049f4f102844d766eca577e809cf21f7908a9d2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.21e-05 | 195 | 17 | 3 | 562e4c0e4e81f6303e57b846da71d1667fc35963 | |
| ToppCell | (0)_NK_cells-(0)_NK_CD160pos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.21e-05 | 195 | 17 | 3 | 6cbeceb52bb207f3c074e57b5b3f7cfb24fd5877 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.21e-05 | 195 | 17 | 3 | fa8ac154e5aebc26463ff84f0ad1038095770bc6 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 5.29e-05 | 196 | 17 | 3 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.29e-05 | 196 | 17 | 3 | 62b2de1d38a99ab23211bf51595845f8a1fdb7d2 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.29e-05 | 196 | 17 | 3 | 9a6e4eea19348a6e3379d3b872456ab6280cb74f | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 5.37e-05 | 197 | 17 | 3 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.37e-05 | 197 | 17 | 3 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | myeloid-Dendritic_cell-Conventional_dendritic_cell|myeloid / Lineage, cell class and subclass | 5.54e-05 | 199 | 17 | 3 | 1e7ce1a1d6a7af18351d64b7a5334efa6dd9abc5 | |
| ToppCell | Bronchial_Biopsy-Immune-Dendritic_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.54e-05 | 199 | 17 | 3 | be916332291ea48e244c05ab1855f9fcd718ac54 | |
| ToppCell | Transverse-T_cell-Th1|T_cell / Region, Cell class and subclass | 5.54e-05 | 199 | 17 | 3 | 9271d9d36ffe1c169049d4340258f366916adfaf | |
| ToppCell | Severe|World / Disease group and Cell class | 5.54e-05 | 199 | 17 | 3 | b73ae402b258fcc17e6cd6d6045244eccfe38ef8 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 5.54e-05 | 199 | 17 | 3 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.54e-05 | 199 | 17 | 3 | 5a29db2610ba06a2248325a16cad755d20debf2c | |
| ToppCell | myeloid-Dendritic_cell|myeloid / Lineage, cell class and subclass | 5.54e-05 | 199 | 17 | 3 | b81c0a40481f1006ac4aa8759af95448cb5fc2e6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.54e-05 | 199 | 17 | 3 | c7c501ad144ac5488d0b0496554d46616f2e01a6 | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.62e-05 | 200 | 17 | 3 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | severe-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.62e-05 | 200 | 17 | 3 | 6aa77955017d073a96324e4db6b9950a2ec46cf8 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 5.62e-05 | 200 | 17 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | myeloid-pro-cDC|myeloid / Lineage and Cell class | 5.62e-05 | 200 | 17 | 3 | 4aa2308eeb94e0bdff4e02eb9e45ba8837ae14bf | |
| ToppCell | severe-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.62e-05 | 200 | 17 | 3 | 2253d74049cc49c92e897ff4aa298d913daeb739 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Tac1-Inhibitory_Gad1Gad2_Id2.Tac1_(Interneuron,_Neurogliaform1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.04e-04 | 56 | 17 | 2 | c1bdee477c871c03d60feed26b24d9f3d4171cb6 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Tac1-Inhibitory_Gad1Gad2_Id2.Tac1_(Interneuron,_Neurogliaform1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.04e-04 | 56 | 17 | 2 | c78cbec68922b382595758e100dda9d284836c25 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.05e-04 | 88 | 17 | 2 | 142d2e00ef19c0ad011a21945bf1111271056eae | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.63e-04 | 93 | 17 | 2 | d84d8fb3f2553364edf4cf5488a2747512fe65af | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.63e-04 | 93 | 17 | 2 | 3223e3e4e1a571bd947949ae545c49cfefe53dce | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.63e-04 | 93 | 17 | 2 | b6653a0eafe0409d7582640706e729202f3b40ea | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.63e-04 | 93 | 17 | 2 | 78de1ca2c5a8511580fa47734df951d0ee5c518a | |
| ToppCell | TCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.31e-04 | 106 | 17 | 2 | 14f548be39cec604fbdae0382cbf434fa4049840 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.31e-04 | 106 | 17 | 2 | 939b80950d39cdc7149a05fdfb64c8810064cdb1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.31e-04 | 106 | 17 | 2 | e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-mDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-03 | 132 | 17 | 2 | f8e2ba53063007d7507f1837ad669b0e4333cd23 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-granulocyte|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.23e-03 | 138 | 17 | 2 | d29eb8d361609048e789334a78c51064c296ad2a | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-03 | 142 | 17 | 2 | d60d2a5d0876a552bc161fc4e2dfe180f88f03a5 | |
| ToppCell | tumor_Lung-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 1.30e-03 | 142 | 17 | 2 | eaf08a0dbacc9ebbd54e377922e76d8ba854dcb8 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.30e-03 | 142 | 17 | 2 | 1e57c75e9f28aae2ca99543448433fa7326398ad | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_3|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.34e-03 | 144 | 17 | 2 | ce5e219f2548b51440b8b3e1a9f011afd4510d19 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|lymph-node_spleen / Manually curated celltypes from each tissue | 1.43e-03 | 149 | 17 | 2 | 32b0a8789d3be4889821afab0b52214deeff7e4d | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-03 | 149 | 17 | 2 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | Dividing_Macrophages-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.49e-03 | 152 | 17 | 2 | e39cfc346b35235546b303e7d73e4d9d7120a5fb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-03 | 154 | 17 | 2 | 3fa6f77ad2c30ec24b9b904e2732ec5b419dff5b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-03 | 154 | 17 | 2 | ee03b386d28a524084eaf1c0091f7389daa34250 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 1.57e-03 | 156 | 17 | 2 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T4|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.61e-03 | 158 | 17 | 2 | 53afcc8132cd61bae1adbdedb83e5bac6690bc8d | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-03 | 158 | 17 | 2 | cf1b77abd05f18526679c0d305b4dd2caef2b306 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-03 | 159 | 17 | 2 | 6ec5489d55667e53bd9c021ada7de458bfef43a3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-03 | 159 | 17 | 2 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-03 | 160 | 17 | 2 | 21f7c0337fbd99e4a20650920d8302d7318bd25e | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.67e-03 | 161 | 17 | 2 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.67e-03 | 161 | 17 | 2 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.67e-03 | 161 | 17 | 2 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.67e-03 | 161 | 17 | 2 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | control-Epithelial-Ciliated-diff|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.67e-03 | 161 | 17 | 2 | ef4b946914a4e2727ed57362dc6965c299520f35 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-03 | 162 | 17 | 2 | 0acb8f7b51bf422d4f4f8e99bd10360163ae4eb7 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-03 | 162 | 17 | 2 | 075f73ff10e1a7f5695e014e47acc4db513e9cfb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.69e-03 | 162 | 17 | 2 | 3b89c3758835b7b9f9d4fb0bc8ed06da382fe48b | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Trm_Th1/Th17|bone_marrow / Manually curated celltypes from each tissue | 1.71e-03 | 163 | 17 | 2 | 4d1fd0b1246833723b938eca0cb246e937380e12 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-03 | 164 | 17 | 2 | 249d8f75a64bce7db52ce0c563f496b9edf602a6 | |
| ToppCell | PSB-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.73e-03 | 164 | 17 | 2 | 3e672124dea2497c5bdf8a315c8cfacfab5780dc | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-03 | 165 | 17 | 2 | 953c8242a81a39ade63ac8e5b34fe58575771746 | |
| ToppCell | Monocytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.75e-03 | 165 | 17 | 2 | 83d06210a50073fbb7082eabd8298dd355c40416 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-03 | 166 | 17 | 2 | 6842735750dcb361e4c9844f05233b0fbb879652 | |
| ToppCell | facs-Heart-RV-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-03 | 166 | 17 | 2 | 16d42eda958b2a6f9d598e9b4b967505dee426ef | |
| ToppCell | facs-Heart-RV-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-03 | 166 | 17 | 2 | 08d7db4ff1c9c9cea3a36a87b8690838e79d4e0e | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-03 | 166 | 17 | 2 | 4ab1959c526c2fd83077fc03e4de207f34841a19 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Liver / Manually curated celltypes from each tissue | 1.77e-03 | 166 | 17 | 2 | 9afa33b5ad27dc33576be592f9b22d8161366838 | |
| ToppCell | Dividing_Macrophages-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.77e-03 | 166 | 17 | 2 | ea95b94ccc2ac67df741b30c27f4ae698925875f | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-03 | 167 | 17 | 2 | d80b64322d16d98c82a52724809740b9de208f39 | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 167 | 17 | 2 | 4a669eafde3582a451614ad304769b47aa1d9578 | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 167 | 17 | 2 | 3c4183a8225bae37b9f5341ebd1b95409ced2022 | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 167 | 17 | 2 | 28e9670586ff551b700c794313d27eedbfa1286b | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-03 | 167 | 17 | 2 | 3c3e1c31aacca48099693aea2efdfa22fc0e4af4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-03 | 167 | 17 | 2 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-03 | 167 | 17 | 2 | 77a4d7ce44847c76074d4f5340d61b398fe43e6c | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 167 | 17 | 2 | 9a8e291c082d7c26bab21df77bd36ce927032a70 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-03 | 168 | 17 | 2 | 696b31bedbc7d40817a733e8c6ec2633404be619 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-mDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-03 | 168 | 17 | 2 | 2dca1c4a33b6da9357fa3b2a523af19baab1c21c | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-03 | 168 | 17 | 2 | 19d2c763b50e7168dfa7449fc407489b055526c2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.14e-03 | 50 | 11 | 2 | GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_STRESS_HSP | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.14e-03 | 50 | 11 | 2 | GAVISH_3CA_METAPROGRAM_B_CELLS_HSP_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.14e-03 | 50 | 11 | 2 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.14e-03 | 50 | 11 | 2 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_HEAT_SHOCK | |
| Drug | 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE | 4.63e-07 | 2 | 16 | 2 | DB07877 | |
| Drug | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL | 4.63e-07 | 2 | 16 | 2 | DB07594 | |
| Drug | 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine | 4.63e-07 | 2 | 16 | 2 | DB02754 | |
| Drug | Geldanamycin | 4.63e-07 | 2 | 16 | 2 | DB02424 | |
| Drug | N-(5-methylisoxazol-3-yl)-2-(4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidin-2-ylthio)acetamide | 2.78e-06 | 4 | 16 | 2 | ctd:C576667 | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 9.49e-06 | 199 | 16 | 4 | 2760_DN | |
| Drug | NSC330499 | 9.70e-06 | 7 | 16 | 2 | CID000433447 | |
| Drug | phenyldichloroarsine | 1.29e-05 | 8 | 16 | 2 | CID000012762 | |
| Drug | 6-anilino-5,8-quinolinedione | 1.66e-05 | 9 | 16 | 2 | ctd:C041715 | |
| Drug | 5,8-quinolinedione | 1.66e-05 | 9 | 16 | 2 | CID000388306 | |
| Drug | Pu-3 | 2.54e-05 | 11 | 16 | 2 | CID000448965 | |
| Drug | AC1L9PMA | 4.84e-05 | 15 | 16 | 2 | CID000451405 | |
| Drug | BHTOH-QM | 7.86e-05 | 19 | 16 | 2 | ctd:C110172 | |
| Drug | dimyristoylphosphatidic acid | 8.73e-05 | 20 | 16 | 2 | CID000093134 | |
| Drug | dimethyl pimelimidate | 8.73e-05 | 20 | 16 | 2 | CID000065403 | |
| Drug | tamoxifen aziridine | 1.06e-04 | 22 | 16 | 2 | CID003033894 | |
| Drug | CCT018159 | 1.06e-04 | 22 | 16 | 2 | CID005327091 | |
| Drug | S2A | 1.16e-04 | 23 | 16 | 2 | CID016058643 | |
| Drug | SC-10 | 1.73e-04 | 28 | 16 | 2 | CID000005175 | |
| Drug | 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone | 1.73e-04 | 28 | 16 | 2 | ctd:C024709 | |
| Drug | TM02 | 1.73e-04 | 28 | 16 | 2 | CID000012902 | |
| Drug | p-iodophenol | 1.86e-04 | 29 | 16 | 2 | CID000010894 | |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | 2.21e-04 | 172 | 16 | 3 | 1159_UP | |
| Drug | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | 2.27e-04 | 32 | 16 | 2 | ctd:C025603 | |
| Drug | prostaglandin A1 | 2.56e-04 | 34 | 16 | 2 | ctd:C100573 | |
| Drug | Adenosine-5'-Diphosphate | 2.88e-04 | 36 | 16 | 2 | DB03431 | |
| Drug | Humic Substances | 2.88e-04 | 36 | 16 | 2 | ctd:D006812 | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.96e-04 | 190 | 16 | 3 | 2619_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 3.14e-04 | 194 | 16 | 3 | 1060_UP | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; HL60; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 2475_DN | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; HL60; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 2936_DN | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 6745_DN | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; HL60; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 2903_DN | |
| Drug | SC-58125; Down 200; 10uM; MCF7; HG-U133A | 3.29e-04 | 197 | 16 | 3 | 208_DN | |
| Drug | Tiabendazole [148-79-8]; Down 200; 19.8uM; HL60; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 2479_DN | |
| Drug | Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 2853_DN | |
| Drug | Estropipate [7280-37-7]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 4472_UP | |
| Drug | Suxibuzone [27470-51-5]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 5806_UP | |
| Drug | AC1L1JAF | 4.50e-04 | 45 | 16 | 2 | CID000004952 | |
| Drug | Albendazole | 4.71e-04 | 46 | 16 | 2 | ctd:D015766 | |
| Drug | AC1L194G | 5.34e-04 | 49 | 16 | 2 | CID000000386 | |
| Drug | tanespimycin | 6.97e-04 | 56 | 16 | 2 | ctd:C112765 | |
| Drug | nickel hydroxide | 7.30e-04 | 259 | 16 | 3 | CID000025500 | |
| Drug | pyrithione zinc | 9.97e-04 | 67 | 16 | 2 | ctd:C010423 | |
| Drug | 2-amino-4,6-dinitrotoluene | 1.09e-03 | 70 | 16 | 2 | ctd:C035208 | |
| Drug | alachlor | 1.12e-03 | 71 | 16 | 2 | CID000002078 | |
| Drug | dimethyl phthalate | 1.29e-03 | 714 | 16 | 4 | ctd:C024629 | |
| Drug | Succimer | 1.37e-03 | 1264 | 16 | 5 | ctd:D004113 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 4.69e-05 | 19 | 16 | 2 | DOID:4928 (is_marker_for) | |
| Disease | muscular atrophy (biomarker_via_orthology) | 1.11e-04 | 29 | 16 | 2 | DOID:767 (biomarker_via_orthology) | |
| Disease | pancreatitis (biomarker_via_orthology) | 2.02e-04 | 39 | 16 | 2 | DOID:4989 (biomarker_via_orthology) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 3.33e-04 | 50 | 16 | 2 | DOID:3770 (biomarker_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 3.80e-04 | 268 | 16 | 3 | DOID:162 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.15e-03 | 93 | 16 | 2 | C1535926 | |
| Disease | HIV Coinfection | 1.40e-03 | 103 | 16 | 2 | C4505456 | |
| Disease | HIV Infections | 1.40e-03 | 103 | 16 | 2 | C0019693 | |
| Disease | QT interval | 2.77e-03 | 534 | 16 | 3 | EFO_0004682 | |
| Disease | Mood Disorders | 3.67e-03 | 168 | 16 | 2 | C0525045 | |
| Disease | obesity (implicated_via_orthology) | 5.93e-03 | 215 | 16 | 2 | DOID:9970 (implicated_via_orthology) | |
| Disease | platelet component distribution width | 7.29e-03 | 755 | 16 | 3 | EFO_0007984 | |
| Disease | platelet crit | 1.37e-02 | 952 | 16 | 3 | EFO_0007985 | |
| Disease | serum non-albumin protein measurement | 1.60e-02 | 361 | 16 | 2 | EFO_0004568 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKCEKLEKDKKMLEE | 786 | Q8IVF6 | |
| KLKELKKEELFTMKL | 181 | Q8TF65 | |
| CELLTVKIKKMEDKV | 746 | Q9UPS8 | |
| AQRKLLMLKKEKLEK | 1331 | Q8IZT6 | |
| LKKLKEAGCKLRIMK | 166 | Q9Y235 | |
| KKLMEKEEKLCIKIL | 1661 | Q14571 | |
| ENLCKLMKEILDKKV | 561 | P08238 | |
| LCKLMKEILDKKVEK | 436 | Q58FF7 | |
| LCKIMKDMLEKKVKK | 256 | Q58FG0 | |
| KEILMLKDKLEKSKR | 731 | Q9Y5S2 | |
| LCKIMKDILEKKVEK | 571 | P07900 | |
| KEKMKRKGCALLVKL | 476 | Q92918 | |
| MLLKKKEECMKKIRE | 931 | Q9UQE7 | |
| EKKLKIILEEMKEKF | 341 | P12757 | |
| LLRDEKKMEKLKQKL | 151 | Q9Y490 | |
| KMEEKEALVKLLLKL | 16 | Q9BQI6 | |
| LKKREEMKLKECVSI | 16 | Q9Y275 |